ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Fate Therapeutics Inc

Fate Therapeutics Inc (FATE)

0,9435
-0,0665
(-6,58%)
Beim Schlusskurs: 14 März 9:00PM
0,95
0,0065
( 0,69% )
Nach Börsenschluss: 12:33AM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
0,95
Gebot
0,90
Fragen
0,9899
Volumen
2.370.608
0,873 Tagesbereich 1,0009
0,87 52-Wochen-Bereich 7,98
Marktkapitalisierung
Handelsende
1,01
Handelsbeginn
0,99
Letzter Handelszeitpunkt
00:33:35
Finanzvolumen
US$ 2.135.955
VWAP
0,901016
Durchschnittliches Volumen (3 Mio.)
2.655.351
Ausgegebene Aktien
113.894.333
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,67
Gewinn pro Aktie (EPS)
-1,41
Erlöse
63,53M
Nettogewinn
-160,93M

Über Fate Therapeutics Inc

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, includ... Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Fate Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker FATE. The last closing price for Fate Therapeutics was US$1,01. Over the last year, Fate Therapeutics shares have traded in a share price range of US$ 0,87 to US$ 7,98.

Fate Therapeutics currently has 113.894.333 shares in issue. The market capitalisation of Fate Therapeutics is US$115,03 million. Fate Therapeutics has a price to earnings ratio (PE ratio) of -0.67.

FATE Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.04294.729357292470.90711.060.8721225410.99104681CS
4-0.33-25.781251.281.810.8734140891.2370376CS
12-0.785-45.24495677231.7351.990.8726553511.38423621CS
26-2.86-75.06561679793.814.170.8725305402.02891138CS
52-6.65-87.57.67.980.8723558333.25649641CS
156-32.26-97.139415838633.2143.120.8722537417.96609362CS
260-20.82-95.636196600821.77121.160.87177291720.43509301CS

FATE - Frequently Asked Questions (FAQ)

What is the current Fate Therapeutics share price?
The current share price of Fate Therapeutics is US$ 0,95
How many Fate Therapeutics shares are in issue?
Fate Therapeutics has 113.894.333 shares in issue
What is the market cap of Fate Therapeutics?
The market capitalisation of Fate Therapeutics is USD 115,03M
What is the 1 year trading range for Fate Therapeutics share price?
Fate Therapeutics has traded in the range of US$ 0,87 to US$ 7,98 during the past year
What is the PE ratio of Fate Therapeutics?
The price to earnings ratio of Fate Therapeutics is -0,67
What is the cash to sales ratio of Fate Therapeutics?
The cash to sales ratio of Fate Therapeutics is 1,7
What is the reporting currency for Fate Therapeutics?
Fate Therapeutics reports financial results in USD
What is the latest annual turnover for Fate Therapeutics?
The latest annual turnover of Fate Therapeutics is USD 63,53M
What is the latest annual profit for Fate Therapeutics?
The latest annual profit of Fate Therapeutics is USD -160,93M
What is the registered address of Fate Therapeutics?
The registered address for Fate Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Fate Therapeutics website address?
The website address for Fate Therapeutics is www.fatetherapeutics.com
Which industry sector does Fate Therapeutics operate in?
Fate Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
RDUSRadius Recycling Inc
US$ 28,67
(109,88%)
47,67k
MRMMEDIROM Healthcare Technologies Inc
US$ 1,18
(90,32%)
4,47M
AAOIApplied Optoelectronics Inc
US$ 23,72
(49,46%)
2,66M
BTOGBit Origin Ltd
US$ 0,381
(39,61%)
4,54M
PRPLPurple Innovation Inc
US$ 0,84
(26,60%)
3,57M
NAYANAYA Biosciences Inc
US$ 0,2401
(-25,23%)
109,91k
MKDWMKDWELL Tech Inc
US$ 0,3214
(-21,15%)
4,13k
RGCRegencell Bioscience Holdings Ltd
US$ 11,24
(-20,23%)
1,96M
LGCBLinkage Global Inc
US$ 0,1845
(-19,22%)
5,91M
STROSutro Biopharma Inc
US$ 1,0892
(-12,86%)
266,47k
ICONIcon Energy Corporation
US$ 0,1311
(-3,60%)
11,35M
LGCBLinkage Global Inc
US$ 0,1845
(-19,22%)
5,91M
ADTXAditxt Inc
US$ 0,0326
(-2,40%)
5,64M
DGLYDigital Ally Inc
US$ 0,0819
(3,15%)
5,02M
HEPAHepion Pharmaceuticals Inc
US$ 0,0364
(-3,70%)
4,61M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen